Episode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success
The Readout Loud
00:00
Dug and Bossian Osana, Founders of Selangene Therapy
altuler: I've known dug since 19 88, and iam a dibotologist in my clinical training. So i've been following this programme for a very long time, and considered it the most promising thing in the field of diobedes. In type one, the dcells are not there, and we know cadaveric transplants can can work. And in type two, which i spent 18 years of my life studying, it's not as clear that would be the thing. Here's all chuiler. Again.
Transcript
Play full episode
